Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 779-798 of 1749
-
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019
(2020-05-14)Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). Design Multicentre, open label, randomised ... -
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
(2020-07-06)Background: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effects versus placebo. We conducted this meta-analysis to compare the safety of HCQ versus ... -
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
(2020-07-03)BACKGROUND Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. METHODS We conducted a ... -
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic
(2020-04)Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention ... -
Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction
(2014)A reverse transcription/polymerase chain reaction (RT/PCR) protocol for the rapid detection and identification of flaviviruses was developed using a set of universal oligonucleotide primers. These primers correspond to ... -
Identification of super-transmitters of SARS-CoV-2
(2020-04-22)A newly emerged coronavirus, SARS-CoV-2, caused severe outbreaks of pneumonia in China in December 2019 and has since spread to various countries around the world. To probe the origin and transmission dynamics of this ... -
Identification of traditional Chinese Medicine syndromes for patients with COVID-19 pneumonia
(2020-03-21)What is this? Early and comprehensive identification of the clinical commonality of COVID is important for early and accurate use of traditional Chinese medicine (TCM). The clinical characteristics and TCM syndrome ... -
Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions
(2020-03-24)Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection exported from mainland China could lead to self-sustained outbreaks in other countries. By February 2020, several countries were reporting ... -
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
(2020-03-26)The ongoing outbreak of viral pneumonia in China and across the world is associated with a new coronavirus, SARS-CoV-2. This outbreak has been tentatively associated with a seafood market in Wuhan, China, where the sale ... -
Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis
(2020-04-03)[Abstract]. Background: Currently, the epidemic of Coronavirus Disease 2019 (COVID‐19) has begun to spread worldwide. We aim to explore reliable evidences for the diagnosis and treatment of the COVID‐19 by analyzing all ... -
Immune response following infection with SARS‐CoV‐2 and other coronaviruses: A rapid review
(2020-09-23)In this review, we systematically searched and summarized the evidence on the immune response and reinfection rate following SARS‐CoV‐2 infection. We also retrieved studies on SARS‐CoV and MERS‐CoV to assess the long‐term ... -
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
(2020-09-19)Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has emerged as an important complication of COVID-19. A systematic review was done to analyze the clinical profile and outcomes in a total of ... -
Immune-epidemiological parameters of the novel coronavirus – a perspective
(2020-04-06)Introduction: At the end of 2019, Wuhan, a city in China with a population of about 11 million, witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has spread to more 199 countries and territories ... -
Immunity after COVID-19: protection or sensitization ?
(2020-05-23)Motivated by historical and present clinical observations, we discuss the possible unfavorable evolution of the immunity (similar to documented antibody-dependent enhancement scenarios) after a first infection with COVID-19. ... -
Immunity Passports for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour
(2020-05-10)Objective: To assess the impact of describing an antibody-positive test result using the terms Immunity and Passport or Certificate, alone or in combination, on perceived risk of becoming infected with SARS-CoV-2 and ... -
The Immunization Program in the Context of the COVID-19 Pandemic, 26 March 2020
(2020-03-26)This document provides guidance regarding the operation of immunization programs in the context of the COVID-19 pandemic. It contains recommendations on vaccination and epidemiological surveillance for vaccine- preventable ... -
Immunological evidence of Zika virus transmission in Thailand
(2016-06)To identify immunological evidence of Zika virus transmission in Thailand. Methods To undertake a preliminary serosurvey of possible exposure to Zika virus, 21 serum samples from cohort of acute undifferentiated fever ...